Suno Funding, Investors & Competitors

Suno has raised $4M across 2 funding rounds, most recently a $3M seed round in June 2025.

See full Suno profile

Last Suno funding round

$3M

Seed · Jun 2025

Cumulative funding Suno raised

$4M

across 2 funding rounds

Key investors in Suno

  • Gray Line Partners

Suno Overview

About Suno

Suno is a Tel Aviv-based medtech firm streamlining access to hearing care through an online platform connecting patients to audiologists for remote diagnostics and treatment. Services include e-prescriptions for hearing aids and virtual fittings compatible with devices from Phonak and Oticon. Operating in Europe and the Middle East, it partners with clinics in 15 countries.


Founded

2022

HQ

United StatesNew York City, NY

Website

suno.tech

Status

Privately held

Customer focus

B2C

Revenue model

Services

Suno Funding History

Suno has raised a total of $4M across 2 funding rounds.

Suno's first fundraising round was a $1M seed round in August 2023. The most recent completed round was a $3M seed round in June 2025.

Suno funding rounds

Suno funding rounds
DateStageInvestorsRaisedDeal Summary
Jun 2025SeedGray Line Partners (lead)$3MSuno Software, a New York-based company founded in 2022, closed a seed round in mid-2025 led by Gray Line Partners, the Seattle growth equity firm that backs early-growth enterprise software businesses. The round was publicised by the company on 13 November 2025 as funding to accelerate its AI product roadmap for hearing clinics. Gray Line partner Eddie Kang described Suno as one of the most exciting companies in hearing care, citing its combination of deep domain expertise and a disciplined AI strategy. The amount was not stated in the announcement. Suno sells an all-in-one practice-management platform for audiology and hearing clinics, covering scheduling, charting, billing, patient communication and analytics. The new capital is directed at AI features such as automated clinical summaries, AI scribes for SOAP notes and real-time analytics. The company is now a software partner to hundreds of hearing clinics across the United States and describes itself as the fastest-growing practice-management solution for hearing clinics.
Aug 2023Seed-$1MSuno Software, a New York-based company founded in 2022, raised its first outside funding in August 2023 as a seed round. The company builds practice-management software for audiology and hearing clinics, bringing scheduling, charting, billing, patient communication and analytics into a single platform. The seed capital funded the early build-out of the product and its first rollout to independent hearing clinics in the United States. The round was followed by a second seed round in mid-2025 led by Gray Line Partners, which took the company's total funding to about USD 3.9 million. Suno has since become a software partner to hundreds of hearing clinics nationwide and is adding AI features such as automated clinical summaries and AI scribes for SOAP notes.

Who has invested in Suno?

1 investor has backed Suno across its funding rounds, including Gray Line Partners.

Lead investors include Gray Line Partners.


Suno Investors

Investors in Suno by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 1 Suno investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Suno Competitors

Suno competitors include listed companies like Max Healthcare Institute, Oscar Health and Hims, and private ones like Devoted Health, Ro and WeDoctor.

Public and private companies comparable to Suno
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Devoted HealthUnited StatesBoston, MAPrivate$3.3B-$16B-
Max Healthcare InstituteIndiaIndiaPublicly listed$874M$236M$9.7B8.9x
Oscar HealthUnited StatesUnited StatesPublicly listed$12B($391M)$9.5B0.5x
RoUnited StatesNew York City, NYPrivate$250M-$7B-
WeDoctorChinaHangzhouPrivate$267M-$7B50.4x
HimsUnited StatesUnited StatesPublicly listed$2.3B$178M$6.1B2.2x

Suno Public Comps

Suno is still privately-owned, but its public comps include Max Healthcare Institute, Oscar Health, Hims, Ping An Healthcare, Teladoc, JMDC, GoodRx, Guiyang Longmaster, Medley Inc. and American Well.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Max Healthcare Institute$874M$236M11.5x8.9x42.4x32.9x
Oscar Health$12B($391M)0.8x0.5x(24.4x)13.2x
Hims$2.3B$178M2.9x2.2x38.0x22.7x
Ping An Healthcare$821M$52M0.8x0.9x12.9x18.1x
Teladoc$2.5B$124M0.7x0.7x14.4x6.2x
JMDC$319M$87M5.1x4.6x18.9x17.8x
GoodRx$797M$173M1.8x1.8x8.3x5.8x
Guiyang Longmaster$45M$5M9.8x-85.9x-

This data is available for Pro users. Sign up to see all Suno competitors and their valuation data.

Start Free Trial

Common questions about Suno

When was Suno founded?Suno was founded in 2022.
Where is Suno headquartered?Suno is headquartered in New York City, NY, United States.
Is Suno publicly listed?No, Suno is a private, VC-backed company.
How much funding has Suno raised?Suno has raised $4M across 2 funding rounds.
What was Suno's last funding round?Suno's last funding round was a $3M seed round in June 2025, led by Gray Line Partners.
Who are Suno's investors?Suno's investors include Gray Line Partners.
Which companies are comparable to Suno?Companies comparable to Suno include Devoted Health, Max Healthcare Institute, Oscar Health, Ro, WeDoctor and Hims.

See companies similar to Suno

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial